Literature DB >> 20214604

Phage choice, isolation, and preparation for phage therapy.

Jason J Gill1, Paul Hyman.   

Abstract

Phage therapy is the use of bacteriophages--viruses that use bacteria as their host cells--as biocontrol agents of bacteria. Currently, phage therapy is garnering renewed interest as bacterial resistance to antibiotics becomes widespread. Historically, phage therapy was largely abandoned in the West in the 1940s due to the advent of chemical antibiotics, and the unreliability of phage-based treatments when compared to antibiotics. The choice of phage strain and the methods of phage preparation are now thought to have been critical to the success or failure of phage therapy trials. Insufficiently virulent phages, especially against actual target bacteria, allow bacteria to survive treatment while poorly prepared phage stocks, even if of sufficiently virulent phages, lack the numbers of viable phages required for adequate treatment. In this review we discuss the factors that determine the methods of isolation, analysis, and identification of phage species for phage therapy. We go on to discuss the various methods available for purifying phages as well as considerations of the degree of purification which is sufficient for various applications. Lastly, we review the current practices used to prepare commercial phage therapy products.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214604     DOI: 10.2174/138920110790725311

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  106 in total

1.  Isolation of Polyvalent Bacteriophages by Sequential Multiple-Host Approaches.

Authors:  Pingfeng Yu; Jacques Mathieu; Mengyan Li; Zhaoyi Dai; Pedro J J Alvarez
Journal:  Appl Environ Microbiol       Date:  2015-11-20       Impact factor: 4.792

Review 2.  Phage therapy for respiratory infections.

Authors:  Rachel Yoon Kyung Chang; Martin Wallin; Yu Lin; Sharon Sui Yee Leung; Hui Wang; Sandra Morales; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2018-08-07       Impact factor: 15.470

3.  Standardized bacteriophage purification for personalized phage therapy.

Authors:  Tiffany Luong; Ann-Charlott Salabarria; Robert A Edwards; Dwayne R Roach
Journal:  Nat Protoc       Date:  2020-07-24       Impact factor: 13.491

4.  Mutant and Recombinant Phages Selected from In Vitro Coevolution Conditions Overcome Phage-Resistant Listeria monocytogenes.

Authors:  Tracey Lee Peters; Yaxiong Song; Daniel W Bryan; Lauren K Hudson; Thomas G Denes
Journal:  Appl Environ Microbiol       Date:  2020-10-28       Impact factor: 4.792

5.  Bacteriophage ecology in a commercial cucumber fermentation.

Authors:  Z Lu; I M Pérez-Díaz; J S Hayes; F Breidt
Journal:  Appl Environ Microbiol       Date:  2012-09-28       Impact factor: 4.792

6.  Genomic and Biochemical Characterization of Acinetobacter Podophage Petty Reveals a Novel Lysis Mechanism and Tail-Associated Depolymerase Activity.

Authors:  A C Hernandez-Morales; L L Lessor; T L Wood; D Migl; E M Mijalis; J Cahill; W K Russell; R F Young; J J Gill
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

7.  Characterization of novel virulent broad-host-range phages of Xylella fastidiosa and Xanthomonas.

Authors:  Stephen J Ahern; Mayukh Das; Tushar Suvra Bhowmick; Ry Young; Carlos F Gonzalez
Journal:  J Bacteriol       Date:  2013-11-08       Impact factor: 3.490

8.  Diversity and geographical distribution of Flavobacterium psychrophilum isolates and their phages: patterns of susceptibility to phage infection and phage host range.

Authors:  Daniel Castillo; Rói Hammershaimb Christiansen; Romilio Espejo; Mathias Middelboe
Journal:  Microb Ecol       Date:  2014-02-21       Impact factor: 4.552

9.  CIM(®) monolithic anion-exchange chromatography as a useful alternative to CsCl gradient purification of bacteriophage particles.

Authors:  Evelien M Adriaenssens; Susan M Lehman; Katrien Vandersteegen; Dieter Vandenheuvel; Didier L Philippe; Anneleen Cornelissen; Martha R J Clokie; Andrés J García; Maurice De Proft; Martine Maes; Rob Lavigne
Journal:  Virology       Date:  2012-10-16       Impact factor: 3.616

Review 10.  Steering Phages to Combat Bacterial Pathogens.

Authors:  James Gurney; Sam P Brown; Oliver Kaltz; Michael E Hochberg
Journal:  Trends Microbiol       Date:  2019-11-16       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.